In 2023, the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK made a significant dent in the illegal medicine trade. They seized more than £30m worth of illicit medications, with over 15.5 million doses being confiscated. The seizures involved an array of prescription drugs like anti-anxiety medications, opioids, and sleeping tablets.
Illegal wellness and aesthetic items, like hair loss treatments and weight loss products containing semaglutide, were among the seized stock. Unlicensed medications pose unique risks as they haven’t undergone MHRA’s rigorous safety, efficacy, or manufacturing quality evaluations. The absence of these assessments means users can’t establish the product’s content for certain.
A global initiative called Operation Pangea contributed 2 million doses to the overall tally. This project aims to counter the unauthorized online trading of medical products. MHRA deputy director of criminal enforcement, Andy Morling, emphasized public safety as their primary concern. Their unit is tirelessly combating illegitimate dealings involving medical products and devices to shield people from these detrimental trades.
Moreover, this year witnessed an unprecedented number of seized drugs, and key strides were made in crippling online illegal trade. Perpetrators were handed prison sentences, their illegal gains were seized, and both online retailers and social media platforms involved in these activities were significantly disrupted.
Illegal medicine dealing online is often executed via counterfeit legitimate pharmacies and online stores. They also use online marketplaces and social media sites. In a year, MHRA, with its partners’ assistance, managed to disrupt over 12,000 illegitimate websites selling medical products to the public. They also deactivated nearly 3,000 social profiles.
Morling advises the public to be extremely cautious when purchasing medication online. It’s suggested always to ascertain the legitimacy of the seller. Obtaining potent drugs from unauthorized sellers is a potential immediate threat to one’s health due to uncertainty about what the products may contain.
